Wall Street Analysts See a 73.42% Upside in Kiniksa Pharmaceuticals (KNSA): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts predict a 73.42% upside for Kiniksa Pharmaceuticals (KNSA), driven by positive earnings estimate revisions.
March 03, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have set a price target indicating a 73.42% upside for Kiniksa Pharmaceuticals, supported by positive earnings estimate revisions.
The article highlights a significant upside potential for KNSA based on analyst price targets and positive earnings estimate revisions. This suggests a likely increase in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100